Compare Natera Inc. Common Stock (NTRA) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Suncor Energy Inc. — how do they compare? Natera Inc. Common Stock trades at $393.27 (market cap $57.03B), while Suncor Energy Inc. trades at $75.96 (market cap $87.48B). The key difference: Suncor Energy Inc. is the larger of the two by market cap, and Suncor Energy Inc. pays a 2.26% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Suncor Energy Inc. for 57 Days on average.
| NTRA | SU | |
|---|---|---|
Market Cap | $57.03B | $87.48B |
Volume | 1,131,157 | 3,692,639 |
Sector | Health | Energy |
52-Week High | $425.64 | $75.89 |
52-Week Low | $179.42 | $38.17 |
Typical Hold Time | 0 Days | 57 Days |
Enterprise Value | $56.18B | $94.00B |
Dividend Yield | — | 2.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Suncor Energy (SU) trades at $75.2, up 2.3% today, near its recent highs. The stock shows strong technical momentum with bullish moving averages, though RSI levels suggest potential overbought conditions. Fundamentally, SU maintains solid profitability with a 14.7% net income margin and trades at a reasonable P/E of 14.32. Recent news highlights asset sales and shareholder returns, while analyst sentiment is overwhelmingly positive with 74% buy ratings.
Outlook: SU's integrated model and aggressive buybacks support upside, but reliance on commodity prices and operational risks pose challenges. The stock offers value with growth potential, yet investors should monitor oil price volatility and execution of strategic initiatives for sustained performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
